Published in
Springer Nature [academic journals on nature.com], Oncogene, 46(38), p. 7181-7195, 2019
DOI: 10.1038/s41388-019-0937-9
Links
Tools
Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9
Journal article published in 2019 by
Kathy-Ann Secker,
Hildegard Keppeler,
Silke Duerr-Stoerzer,
Hannes Schmid,
Dominik Schneidawind,
Thomas Hentrich,
Julia M. Schulze-Hentrich,
Barbara Mankel,
Falko Fend 
,
Corina Schneidawind
,
Corina Schneidawind
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 